Imaging Neuroleptic Compounds

A method for identifying typical and atypical antipsychotics based on their ability to reduce neuronal/glial activity in specific brain regions upon dopaminergic neurotransmission is disclosed.

Attached files:
WO 2010028133.jpg

WO 2,010,028,133

Inventor(s): FERRIS CRAIG [US]

Type of Offer: Licensing

Next Patent »
« More Biotech Patents

Share on      

CrowdSell Your Patent